Ultrasonography can guide drug modification in arthritis

August 26, 2016

(HealthDay)—Ultrasonography can be useful for guiding modification of anti-rheumatic drugs and steroids for patients with inflammatory arthritis (IA), according to a study published online Aug. 19 in the International Journal of Rheumatic Diseases.

York Kiat Tan, M.B.B.S., from Singapore General Hospital, and colleagues conducted a retrospective study involving 46 adult IA patients to examine the utility of ultrasonography in guiding modification of disease-modifying anti-rheumatic drug (DMARD) and steroid therapy. Data were analyzed for 37 patients with both power Doppler (PD) vascularity and greyscale (GS) synovial hypertrophy joint findings.

The researchers found that all 10 patients escalated and/or initiated on DMARD and nine of 10 patients escalated or initiated on were positive for PD and GS. PD-negative findings were seen in six of seven patients with dose reduction and/or cessation of DMARDs and five of seven with dose reduction or cessation of steroids. Six were GS-positive and PD-negative; of these, three had dose reduction or cessation of DMARDs and four had dose reduction of steroids; none had DMARD/steroid escalation.

"Ultrasonography of physician-selected joints can improve clinical assessment, resulting in treatment modification," the authors write. "Positive PD findings were particularly influential, while the clinical significance of GS positivity alone requires further investigation."

Explore further: Dose reduction strategy can substantially reduce high cost of TNF inhibitor therapy in RA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Dose reduction strategy can substantially reduce high cost of TNF inhibitor therapy in RA

June 13, 2015
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour ...

DMARDs may be underused for low back pain

June 15, 2015
(HealthDay)—Disease-modifying antirheumatic drugs (DMARDs) may be underutilized for treatment of low back pain (LBP), according to a review published online June 1 in Pain Practice.

Diabetes risk of common arthritis medicine quantified for first time

May 4, 2016
Glucocorticoid (or steroid) therapy, prescribed to around half of patients with rheumatoid arthritis, is a known risk factor for developing diabetes. A study from The University of Manchester has found how the risk of diabetes ...

Low dose steroids linked to diabetes

February 11, 2014
(Medical Xpress)—Anti-inflammatory steroids are known to increase the risk of diabetes in high doses, but now researchers from Flinders University have discovered a link between low dose steroids and diabetes.

EULAR issues updated rheumatoid arthritis management recommendations

July 3, 2013
The European League Against Rheumatism (EULAR) has released updated recommendations for the management of RA. According to this latest guidance, treatment with disease-modifying anti-rheumatic drugs (DMARDs) should be initiated ...

Use of certain therapies for inflammatory diseases does not appear to increase risk of shingles

March 5, 2013
Although patients with rheumatoid arthritis (RA) have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that ...

Recommended for you

New osteoarthritis genes discovered

March 19, 2018
In the largest study of its kind, nine novel genes for osteoarthritis have been discovered by scientists from the Wellcome Sanger Institute and their collaborators. Results of the study, published today (19 March) in Nature ...

Rheumatoid arthritis meets precision medicine

March 19, 2018
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site ...

Scientists use nanotechnology to detect molecular biomarker for osteoarthritis

March 12, 2018
For the first time, scientists at Wake Forest Baptist Medical Center have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology.

Biological engineers discover why a promising drug failed in clinical trials

March 7, 2018
Pharmaceutical companies once considered a protein called p38 a very attractive target for treating rheumatoid arthritis. Arthritis patients usually have elevated activity of this inflammation-producing protein, and in lab ...

Scorpion venom component can reduce severity of rheumatoid arthritis

February 26, 2018
A treatment that improves the lives of nearly 1.3 million people with rheumatoid arthritis might one day originate from scorpion venom. A group of researchers led by Dr. Christine Beeton at Baylor College of Medicine has ...

New device for low-cost single-cell analysis identifies fibroblast subtypes in rheumatoid arthritis patients

February 23, 2018
Single-cell analysis holds enormous potential to study how individual cells influence disease and respond to treatment, but the lack of cost-effective and user-friendly instrumentation remains challenging. As described in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.